Yakhshimurodov U, Yamashita K, Kawamura T, Kawamura M, Miyagawa S. Paradigm shift in myocarditis treatment. J Cardiol. 2023.
Brooks TR, Caimi PF. A paradox of choice: Sequencing therapy in relapsed/refractory diffuse large B-cell lymphoma. Blood Rev. 2023:101140.
Wang J, Zhang C, Huang Y, Ruan Y, Hu Y, Wang J, Wang F, Yu M, Xu Y, Liu L, et al. Parallel genome-wide CRISPR screens to identify state-dependent self-renewal regulators of mouse embryonic stem cells. Stem Cells Dev. 2023.
Corenblum MJ, McRobbie-Johnson A, Carruth E, Bernard K, Luo M, Mandarino LJ, Peterson S, Sans-Fuentes MA, Billheimer D, Maley T, et al. Parallel Neurodegenerative Phenotypes in Sporadic Parkinson's Disease Fibroblasts and Midbrain Dopamine Neurons. Prog Neurobiol. 2023:102501.
Nagy Á, Bátai B, Kiss L, Gróf S, Király PAttila, Jóna Á, Demeter J, Sánta H, Bátai A, Pettendi P, et al. Parallel testing of liquid biopsy (ctDNA) and tissue biopsy samples reveals a higher frequency of EZH2 mutations in follicular lymphoma. J Intern Med. 2023.
Nuttle X, Burt ND, Currall B, Moyses-Oliveira M, Mohajeri K, Bhavsar R, Lucente D, Yadav R, Tai DJC, Gusella JF, et al. Parallelized engineering of mutational models using piggyBac transposon delivery of CRISPR libraries. Cell Rep Methods. 2023:100672.
Nguyen M-U, Potgieter S, Huang W, Pfeffer J, Woo S, Zhao C, Lawlor M, Yang R, Halstead A, Dent S, et al. paralogs prevent dsRNA accumulation and interferon signaling to maintain intestinal stem cells. bioRxiv. 2023.
Bennett JRuina, Ishikawa C, Agarwal P, Yeung J, Sampson A, Uible E, Vick E, Bolanos L, Hueneman KM, Wunderlich M, et al. Paralog-specific signaling by IRAK1/4 maintains MyD88-independent functions in MDS/AML. Blood. 2023.
Haque E, Muhsen IN, Rasheed W, Fakih REl, Aljurf M. Parasitic infections in hematopoietic stem cell transplant recipients. Transpl Infect Dis. 2023:e14160.
Guo Z, Huang T, Liu Y, Liu C. Parathyroid Hormone-Related Protein Promotes the Proliferation of Patient-Derived Glioblastoma Stem Cells via Activating cAMP/PKA Signaling Pathway. Int J Stem Cells. 2023.
Yoon S-H, Meyer MB, Rivas CArevalo, Tekguc M, Zhang C, Wang JS, Andrade CDCastro, Strauss KE, Sato T, Benkusky N, et al. A parathyroid hormone/salt-inducible kinase signaling axis controls renal vitamin D activation and organismal calcium homeostasis. J Clin Invest. 2023.
Ward J, Smith J, Powers K, Hellsten M, Murray P. Parent Psychological Distress is Associated with Symptom Burden and Health-Related Quality of Life in Children and Adolescents Undergoing Stem Cell Transplantation or Chimeric Antigen Receptor-T Therapy. Transplant Cell Ther. 2023.
Zhang G, Ren Q, Lin Y, Zhou D, Huang L, Li W, Chang H, Huang G, Huang G, Li Z, et al. Parental folic acid deficiency delays neurobehavioral development in rat offspring by inhibiting the differentiation of neural stem cells into neurons. J Nutr Biochem. 2023:109455.
Crouch EE, Damas C, Bartrug WC, Shamiyeh A, Scelfo M, Dreyfus M, Gano D, Segal S, Franck LS. Parents' Views on Autopsy, Organ Donation, and Research Donation After Neonatal Death. JAMA Netw Open. 2023;6(11):e2341533.
Kang H, Park S, Jo A, Mao X, Kumar M, Park C-H, Ahn J-Y, Lee Y, Choi J-Y, Lee Y-S, et al. PARIS undergoes liquid-liquid phase separation and poly(ADP-ribose)-mediated solidification. EMBO Rep. 2023:e56166.
Zhu L, Wang Y, Jin S, Niu Y, Yu M, Li Z, Chen L, Wu X, Ding C, Wu T, et al. Parishin A-loaded mesoporous silica nanoparticles modulate macrophage polarization to attenuate tendinopathy. NPJ Regen Med. 2023;8(1):14.
Albalawi M, Alwasaidi T, Almohammadi M, Alzarief AAhmad, Elyamany G. Paroxysmal nocturnal hemoglobinuria in a patient post COVID-19 virus infection: A case report with literature review. Clin Case Rep. 2023;11(10):e8011.
Kunwor R, Silver DP, Abu-Khalaf M. PARP Inhibitors for the Treatment of BRCA1/2-Mutated Metastatic Breast Cancer: A Systematic Review and Meta-analysis. Hematol Oncol Stem Cell Ther. 2023;16(3):186-196.
Cao G, Guo R, Chen M, Sun C, Wang J. PARP12 regulates mouse oocyte meiotic maturation. J Cell Physiol. 2023.
O'Neill MJ, Yang T, Laudeman J, Calandranis M, Solus J, Roden DM, Glazer AM. ParSE-seq: A Calibrated Multiplexed Assay to Facilitate the Clinical Classification of Putative Splice-altering Variants. medRxiv. 2023.
Sun J, Li L, Xiong L, Chen F, She L, Tang H, Zeng Y, Duan Y, Li L, Wang W, et al. Parthenolide alleviates cognitive dysfunction and neurotoxicity via regulation of AMPK/GSK3β(Ser9)/Nrf2 signaling pathway. Biomed Pharmacother. 2023;169:115909.
Gehren AS, de Souza WF, Sousa-Squiavinato ACM, Ramos DAA, Pires BRB, Abdelhay ESFW, Morgado-Díaz JA. Parthenolide inhibits proliferation and invasion, promotes apoptosis, and reverts the cell-cell adhesion loss through downregulation of NF-κB pathway TNF-α-activated in colorectal cancer cells. Cell Biol Int. 2023.
Su Y-R, Gu S-M, Liu Y-R, Cheng Y-Q, Wan Q, Sang X, Chen M-H, Liu W-Q, Shi Q, Liu C, et al. Partial cellular reprogramming stably restores the stemness of senescent epidermal stem cells. Eur Rev Med Pharmacol Sci. 2023;27(12):5397-5409.
Kim J, Kim S, Lee S-Y, Jo B-K, Oh J-Y, Kwon E-J, Kim K-T, Adpaikar AAshok, Kim E-J, Jung H-S, et al. Partial in vivo reprogramming enables injury-free intestinal regeneration via autonomous induction. Sci Adv. 2023;9(47):eadi8454.
Brothers J, Castillo DRan, Jeon WJin, Joung B, Linhares Y. Partial response to venetoclax and ruxolitinib combination in a case of refractory T-prolymphocytic leukemia. Hematology. 2023;28(1):2237342.